I dont think you can tell even which way it will impactSay, GLP-1, I know that it has these properties where it makes people eat less and evidently it makes you able to study better and do a few other things like it gives you a little bit of a little bit more will or something like that, which is interesting
Thus, the evoke/evoke+ trials could provide a much needed catalyst for Novo Nordisk, especially following the questions raised by REDEFINE 1 around CagriSema, despite the latter delivering perfectly reasonable weight loss
The common factors among this group include having established strong exercise habits during treatment (particularly resistance training), having completely overhauled eating patterns with a focus on high-protein whole-food diets, gradual tapering rather than abrupt discontinuation, and having lost weight slowly enough for metabolic adaptation to partially recalibrate
Some individuals may notice weight loss within a few weeks of starting the medication, while others may take a few months to see significant changes
This is the most troubling category of negative reviews